Douglas P. Baker's most recent trade in OptimizeRx Corp was a trade of 10,000 Common Stock done at an average price of $7.5 . Disclosure was reported to the exchange on Oct. 5, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| OptimizeRx Corp | Douglas P. Baker | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.51 per share. | 05 Oct 2021 | 10,000 | 44,796 (0%) | 0% | 7.5 | 75,100 | Common Stock |
| OptimizeRx Corp | Douglas P. Baker | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Oct 2021 | 10,000 | 34,699 | - | - | Stock Option | |
| OptimizeRx Corp | Douglas P. Baker | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 82.35 per share. | 05 Oct 2021 | 10,000 | 34,796 (0%) | 0% | 82.4 | 823,500 | Common Stock (pursuant to 10B5-1 plan) |
| OptimizeRx Corp | Douglas P. Baker | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 84.22 per share. | 05 Oct 2021 | 4,000 | 34,796 (0%) | 0% | 84.2 | 336,880 | Common Stock (pursuant to 10B5-1 plan) |
| OptimizeRx Corp | Douglas P. Baker | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 74.66 per share. | 28 Sep 2021 | 2,000 | 38,796 (0%) | 0% | 74.7 | 149,320 | Common Stock (pursuant to 10B5-1 plan) |